Sosei Group Corporation announced the appointment of Andrew Oakley as Chief Financial Officer effective from February 1, 2017. Mr. Oakley will be based in Sosei's Tokyo offices. Mr. Oakley will succeed Mr. Hidetoshi Torami who has resigned from Sosei for personal reasons. Mr. Oakley had a wide and varied financial career and over the past 14 years has held CFO positions in several publicly listed biotechnology companies including Actelion Ltd, Novimmune SA, and most recently at Vectura Group plc, where he was also a member of the Board.